Insider Buying: Cerecor Inc (NASDAQ:CERC) Director Purchases 56,842 Shares of Stock

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc acquired 56,842 shares of the company’s stock in a transaction on Wednesday, August 14th. The shares were acquired at an average price of $3.37 per share, for a total transaction of $191,557.54. Following the completion of the acquisition, the director now directly owns 400,000 shares in the company, valued at $1,348,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Armistice Capital, Llc also recently made the following trade(s):

  • On Monday, August 12th, Armistice Capital, Llc acquired 13,970 shares of Cerecor stock. The shares were acquired at an average price of $3.20 per share, for a total transaction of $44,704.00.
  • On Wednesday, June 5th, Armistice Capital, Llc purchased 5,000 shares of Cerecor stock. The stock was purchased at an average price of $4.97 per share, with a total value of $24,850.00.
  • On Monday, June 3rd, Armistice Capital, Llc purchased 10,000 shares of Cerecor stock. The stock was purchased at an average price of $4.73 per share, with a total value of $47,300.00.
  • On Thursday, May 30th, Armistice Capital, Llc purchased 18,200 shares of Cerecor stock. The stock was purchased at an average price of $4.64 per share, with a total value of $84,448.00.
  • On Tuesday, May 28th, Armistice Capital, Llc purchased 3,500 shares of Cerecor stock. The stock was purchased at an average price of $4.92 per share, with a total value of $17,220.00.
  • On Thursday, May 23rd, Armistice Capital, Llc purchased 14,100 shares of Cerecor stock. The stock was purchased at an average price of $5.05 per share, with a total value of $71,205.00.
  • On Thursday, May 16th, Armistice Capital, Llc purchased 8,202 shares of Cerecor stock. The stock was purchased at an average price of $5.15 per share, with a total value of $42,240.30.

Shares of CERC opened at $3.59 on Friday. The stock has a fifty day moving average price of $4.45 and a 200 day moving average price of $5.14. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.91 and a current ratio of 0.74. Cerecor Inc has a 12 month low of $2.71 and a 12 month high of $7.65.

A number of equities research analysts have recently weighed in on CERC shares. Maxim Group set a $10.00 price target on Cerecor and gave the company a “buy” rating in a report on Friday, August 9th. HC Wainwright set a $11.00 price target on Cerecor and gave the company a “buy” rating in a report on Monday, July 15th. ValuEngine upgraded Cerecor from a “hold” rating to a “buy” rating in a report on Thursday, August 1st. TheStreet downgraded Cerecor from a “c-” rating to a “d+” rating in a report on Wednesday, May 29th. Finally, LADENBURG THALM/SH SH reiterated a “buy” rating and issued a $8.00 price target on shares of Cerecor in a report on Tuesday, July 2nd. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $9.67.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. grew its stake in Cerecor by 4,046.6% during the 2nd quarter. BlackRock Inc. now owns 1,205,533 shares of the company’s stock worth $6,559,000 after buying an additional 1,176,460 shares during the last quarter. Vanguard Group Inc. grew its stake in Cerecor by 56.5% during the 2nd quarter. Vanguard Group Inc. now owns 678,000 shares of the company’s stock worth $3,689,000 after buying an additional 244,657 shares during the last quarter. Wells Fargo & Company MN bought a new position in Cerecor during the 2nd quarter worth $853,000. Geode Capital Management LLC grew its stake in Cerecor by 50.7% during the 4th quarter. Geode Capital Management LLC now owns 94,990 shares of the company’s stock worth $306,000 after buying an additional 31,951 shares during the last quarter. Finally, Spark Investment Management LLC grew its stake in Cerecor by 60.5% during the 1st quarter. Spark Investment Management LLC now owns 83,000 shares of the company’s stock worth $484,000 after buying an additional 31,290 shares during the last quarter. Hedge funds and other institutional investors own 54.18% of the company’s stock.

Cerecor Company Profile

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device.

See Also: What is Compound Interest?

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.